Cargando…
Correction: THBS2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma
Autores principales: | Gimotty, Phyllis A., Till, Jacob E., Udgata, Shirsa, Takenaka, Naomi, Yee, Stephanie S., LaRiviere, Michael J., O’Hara, Mark H., Reiss, Kim A., O’Dwyer, Peter, Katona, Bryson W., Herman, Daniel, Carpenter, Erica L., Zaret, Kenneth S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629808/ https://www.ncbi.nlm.nih.gov/pubmed/36322403 http://dx.doi.org/10.18632/oncotarget.28127 |
Ejemplares similares
-
THBS2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma
por: Gimotty, Phyllis A., et al.
Publicado: (2021) -
Differential Expression Pattern of THBS1 and THBS2 in Lung Cancer: Clinical Outcome and a Systematic-Analysis of Microarray Databases
por: Weng, Tzu-Yang, et al.
Publicado: (2016) -
Reciprocal regulation of long noncoding RNAs THBS4-003 and THBS4 control migration and invasion in prostate cancer cell lines
por: Liu, Jinliang, et al.
Publicado: (2016) -
Prognostic and Immunological Role of THBS2 in Colorectal cancer
por: Deng, Bin, et al.
Publicado: (2021) -
Genetic regulation of THBS1 methylation in diabetic retinopathy
por: Li, Yaqi, et al.
Publicado: (2022)